Elsevier

Process Biochemistry

Volume 96, September 2020, Pages 11-20
Process Biochemistry

Molecular profiling of marine endophytic fungi from green algae: Assessment of antibacterial and anticancer activities

https://doi.org/10.1016/j.procbio.2020.05.012Get rights and content

Highlights

Abstract

Bioactive natural metabolites, especially from the marine endophytic fungi, are largely unexplored. Endophytic fungi are being increasingly recognized as a group of organisms that produce novel metabolites of industrial importance. This study investigated the anticancer and antibacterial potential of the marine algal endophyte, Penicillium chrysogenum. The different organic solvent extracts of the endophytic fungi grown on different growth medium were analyzed for anticancer and antibacterial activities. The highest inhibitory activity was observed for the ethyl acetate (EA) extract of the culture filtrate grown in potato dextrose broth (PDB) for 21 days, against the tested human breast cancer cell (MCF-7) line. Similarly, the PDB-EA extract showed an appreciable activity against the human pathogens. The biochemical analysis of the Cha EA metabolites revealed terpenoids, steroids, phenolics and flavones. Gas Chromatography (GCsingle bondMS) data revealed several bioactive compounds such as anthraquinone and cinnamic acid. The Cha EA extract induced membrane damage and thus, apoptosis in MCF-7cells. The secondary metabolites produced by these marine endophytic fungi have contributed to considerable anticancer and antimicrobial activities and hence, this study is an evidence of potential sources of antimicrobial and anticancer compounds from Penicillium chrysogenum.

Introduction

The quest for new potent drugs has always persisted crucial throughout human history. Most of the naturally derived metabolites are by products of microorganisms [1]. Around 10% of the world's biodiversity has been investigated for potential bioactivities, however, still, there are many more lead natural metabolites awaiting discovery [2]. The discovery of marine associated metabolites initially exploited macro organisms such as sponges, corals, and algae. However, now the focus has been shifted onto marine microorganisms such as fungi and bacteria [3]. Natural products and naturally derived compounds are generated by marine microorganisms, which have been used for treating human diseases [4]. Natural products derived from marine algae have been the basis of the treatment of several human diseases and thus, natural products are still considered to be valuable sources of drug leads [5].

The marine diversity is well known for incomparable groups of macro and microorganisms generating a wide range of secondary metabolites. Endophytes usually have a mutual relationship with their hosts [6] and most of them produce novel secondary metabolites of industrial potential [7]. Endophytic fungi are chemical synthesizers [8] and ubiquitous organisms, which are found associated with marine algae, residing intercellular or intracellular. The diversity in the marine environment influences the researchers to explore marine microflora with an array of beneficial aspects; the interactions between the marine microbial diversity and algae have opened new avenues in the synthesis of new metabolites.

Endophytic fungi reside in the marine algal living tissues and are potential sources of novel natural products for exploitation in medicine, agriculture, and industry [[9], [10], [11]]. There are only few studies on the marine algal endophytes as a source of natural products of pharmaceutical and agricultural importance [12]. Therefore, the bioprospecting endophytes offer a tremendous promise in the discovery of associated marine algal secondary metabolites, and novel lead compounds with therapeutic potential. Valuable products from microbial sources are usually easier and more economical to produce.

There are several reports on the anticancer and antimicrobial activities of the endophytic isolates from various marine algae [13,14]. However, the endophytes of Chaetomorpha antennina, and their anticancer and antimicrobial values have not yet been investigated. In this course of investigation, the endophytic fungi from the marine algae C. antennina, collected from Kovalam and Chennai, India were isolated and screened for bioactive metabolites. Further, the bioactive compounds were identified using hyphenated techniques.

Section snippets

Chemicals and solvents

Dulbecco's Modified Eagle's Medium (DMEM) and dimethyl sulphoxide (DMSO) were purchased from Sigma Aldrich, USA. Fetal Bovine Serum (FBS) and trypsin-EDTA were procured from GIBCO-BRL. Potato Dextrose Agar and broth were obtained from Himedia, India. Antibiotics and 3-(4, 5-dimethylthiazole-2 yl)-2, 5-diphenyl tetrazolium bromide (MTT) were purchased from SRL-Ranbaxy, India. Ethyl acetate (EA), hexane, chloroform, dichloromethane (DCM) and methanol were bought from Merck, India. All the

Results and discussion

Marine organisms have provided several pharmaceutical products [17]. Endophytic fungi living inside the marine algae are the powerhouses of biologically active and important metabolites. The marine algal endophytic fungal symbionts are good sources of bioactive compounds. Most of the novel anticancer, antiviral and antidiabetic compounds are reported as medicinal entities [18]. Hence, it is suggested to develop alternative drugs in an ecofriendly manner.

Conclusion

The present study has investigated the anticancer and antibacterial activities of the endophytic fungi, P. chrysogenum collected from the marine algae, C. antennina. The Cha EA extract inhibited the HeLa cells and the apoptotic cell death was observed by the live dead cell assay using PI and AO/PI staining. Further, the purification of the bioactive metabolites from P. chrysogenum is under process to get novel bioactive compounds. This study suggests that unravelling fungal endophytes from

CRediT authorship contribution statement

Ramalingam Parthasarathy: Conceptualization, Methodology, Writing - original draft. Manjegowda Chandrika: Investigation, Writing - original draft. H.C. Yashavantha Rao: Writing - review & editing. Subban Kamalraj: Writing - review & editing. Chelliah Jayabaskaran: Supervision, Project administration, Writing - original draft. Arivalagan Pugazhendhi: Supervision, Project administration, Writing - original draft.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgment

This study was supported by a grant from the Department of Science and Technology-Science and Engineering Research Board (DST-SERB) Govt. of India, New Delhi (Ref. no. Dr. R. Parthasarathy Ramalingam PDF/2017/001184). Dr. R. Parthasarathy thank DST-SERB for financial support. Authors thank FACS central facility, Department of Biochemistry, Division of Biological Sciences, Indian Institute of Science (IISc), Bangalore. Dr. R. Parthasarathy also acknowledge Prof. M. Sathiyabama, Department of

References (35)

  • J.W. Blunt et al.

    Marine natural products

    Nat. Prod. Rep.

    (2006)
  • A.L.L.D. Oliveira et al.

    Marine natural products: chemical and biological potential of seaweeds and their endophytic fungi

    Rev. Bras. Farmacogn.

    (2012)
  • A.E. Arnold et al.

    Are tropical fungal endophytes hyperdiverse?

    Ecol. Lett.

    (2000)
  • S. Kusari et al.

    Are we ready for industrial production of bioactive plant secondary metabolites utilizing endophytes?

    Nat. Prod. Rep.

    (2011)
  • N.L. Owen et al.

    Endophytes—The chemical synthesizers inside plants

    Sci. Prog. (New Haven)

    (2004)
  • B. Guo et al.

    Cytonic acids A and B: Novel tridepside inhibitors of hCMV protease from the endophytic fungus cytonaema species

    J. Nat. Prod.

    (2000)
  • G. Strobel et al.

    Bioprospecting for microbial endophytes and their natural products

    Microbiol. Mol. Biol. Rev.

    (2003)
  • Cited by (0)

    View full text